290 related articles for article (PubMed ID: 2139359)
21. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
[TBL] [Abstract][Full Text] [Related]
22. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
23. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Overgaard J; Radacic MM; Grau C
Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
[TBL] [Abstract][Full Text] [Related]
24. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
25. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
Teicher BA; Herman TS; Holden SA; Rudolph MB
Cancer Lett; 1991 Aug; 59(2):109-17. PubMed ID: 1884367
[TBL] [Abstract][Full Text] [Related]
26. Postirradiation modification of tumor blood flow: a method to increase the effectiveness of chemical radiosensitizers.
Chaplin DJ
Radiat Res; 1988 Aug; 115(2):292-302. PubMed ID: 3406369
[TBL] [Abstract][Full Text] [Related]
27. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH
Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235
[TBL] [Abstract][Full Text] [Related]
28. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.
Ning SC; Hahn GM
Cancer Res; 1991 Nov; 51(21):5910-4. PubMed ID: 1718588
[TBL] [Abstract][Full Text] [Related]
30. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
Nishita T
Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
[TBL] [Abstract][Full Text] [Related]
32. Combination and individual antitumor effects of hyperthermia, cisplatin, and selected dithiocarbamates.
Walker EM; Schaefer RF; Henle KJ; Schmidt BJ; Gale GR; Cannon DJ; Jones MM; Moss AJ
Ann Clin Lab Sci; 1989; 19(4):242-54. PubMed ID: 2757352
[TBL] [Abstract][Full Text] [Related]
33. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
Herman TS; Teicher BA; Holden SA
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
[TBL] [Abstract][Full Text] [Related]
34. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
Murthy MS; Rao LN; Khandekar JD; Scanlon EF
Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
[TBL] [Abstract][Full Text] [Related]
35. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
36. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Mulcahy RT; Dembs N
Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
[TBL] [Abstract][Full Text] [Related]
37. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
38. Hyperthermic enhancement of cis-diamminedichloroplatinum (II)-induced DNA damage in human esophageal cancer transplantable to nude mice.
Yano T; Nakatani K; Nakano H; Ihara M; Ohnishi T
Anticancer Res; 1993; 13(6A):1989-97. PubMed ID: 8297105
[TBL] [Abstract][Full Text] [Related]
39. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
Iga K; Hamaguchi N; Igari Y; Ogawa Y; Gotoh K; Ootsu K; Toguchi H; Shimamoto T
J Pharmacol Exp Ther; 1991 Jun; 257(3):1203-7. PubMed ID: 2046024
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
Kusumoto T; Holden SA; Ara G; Teicher BA
Int J Hyperthermia; 1995; 11(4):575-86. PubMed ID: 7594810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
